scispace - formally typeset
M

Mary D. King

Researcher at University College Dublin

Publications -  135
Citations -  5573

Mary D. King is an academic researcher from University College Dublin. The author has contributed to research in topics: Epilepsy & Encephalopathy. The author has an hindex of 36, co-authored 131 publications receiving 4663 citations. Previous affiliations of Mary D. King include Temple University & Temple Street Children's University Hospital.

Papers
More filters
Journal ArticleDOI

Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection.

TL;DR: It is shown that AGS can result from mutations in the genes encoding any one of its three subunits, demonstrating a role for ribonuclease H in human neurological disease and suggesting an unanticipated relationship between ribonUClease H2 and the antiviral immune response that warrants further investigation.
Journal ArticleDOI

Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.

Yanick J. Crow, +135 more
TL;DR: A robust relationship between mutations in all seven genes with increased type I interferon activity in cerebrospinal fluid and serum, and the increased expression of interferOn‐stimulated gene transcripts in peripheral blood is observed.
Journal ArticleDOI

Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome

Gillian I. Rice, +117 more
TL;DR: The analysis defines the phenotypic spectrum of AGS and suggests a coherent mutation-screening strategy in this heterogeneous disorder, and indicates that at least one further AGS-causing gene remains to be identified.
Journal ArticleDOI

A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy

Mikko Muona, +61 more
- 01 Jan 2015 - 
TL;DR: In insights into the molecular genetic basis of PME, the role of de novo mutations in this disease entity is shown and their phenotypic spectra are expanded.
Journal ArticleDOI

Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie

TL;DR: The delineation of a novel type of CDG identified in 2 children presenting with severe developmental delay, seizures, and dysmorphic features was named CDG-Ie, and mannose supplementation failed to improve the glycosylation status of DPM1-deficient fibroblast cells, thus precluding a possible therapeutic application of mannosed in the patients.